COLD AGGLUTININ DISEASE
Clinical trials for COLD AGGLUTININ DISEASE explained in plain language.
Never miss a new study
Get alerted when new COLD AGGLUTININ DISEASE trials appear
Sign up with your email to follow new studies for COLD AGGLUTININ DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug boosts red blood cells in rare disease
Disease control CompletedThis study tested a drug called pegcetacoplan in 24 adults with cold agglutinin disease, a rare condition where the immune system destroys red blood cells. The goal was to see if the drug could raise hemoglobin levels and reduce the need for blood transfusions. Participants recei…
Matched conditions: COLD AGGLUTININ DISEASE
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated May 17, 2026 10:38 UTC
-
Continued access to sutimlimab for cold agglutinin disease patients in japan
Disease control CompletedThis study gave sutimlimab to 7 adults with cold agglutinin disease (CAD) who had already completed earlier studies and still needed treatment. The goal was to keep providing the drug until it became commercially available in Japan. Researchers tracked side effects and serious si…
Matched conditions: COLD AGGLUTININ DISEASE
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 17, 2026 10:26 UTC